Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1982 Oct;16(4):761–762. doi: 10.1128/jcm.16.4.761-762.1982

Clinical laboratory evaluation of a reverse CAMP test for presumptive identification of Clostridium perfringens.

A G Buchanan
PMCID: PMC272466  PMID: 6296196

Abstract

Ninety-six percent of Clostridium perfringens isolates from clinical specimens were reverse CAMP test positive, whereas several other Clostridium species tested were reverse CAMP test negative. C. perfringens was detected by direct inoculation of clinical specimens to reverse CAMP plates, and the reverse CAMP procedure provided reliable presumptive identification of this organism.

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gubash S. M. Synergistic hemolysis phenomenon shown by an alpha-toxin-producing Clostridium perfingens and streptococcal CAMP factor in presumptive streptococcal grouping. J Clin Microbiol. 1978 Nov;8(5):480–488. doi: 10.1128/jcm.8.5.480-488.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hansen M. V., Elliott L. P. New presumptive identification test for Clostridium perfringens: reverse CAMP test. J Clin Microbiol. 1980 Oct;12(4):617–619. doi: 10.1128/jcm.12.4.617-619.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. McClung L. S., Toabe R. The Egg Yolk Plate Reaction for the Presumptive Diagnosis of Clostridium sporogenes and Certain Species of the Gangrene and Botulinum Groups. J Bacteriol. 1947 Feb;53(2):139–147. doi: 10.1128/jb.53.2.139-147.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES